Singapore: Associate Professor Tiziano Barberi and Dr Isabella Mengarelli from the Australian Regenerative Medicine Inst...
Singapore: Israel-based Andain has come up with a new technology called Orcell that rehabilitates and heals damaged musc...
Singapore: China Cord Blood Corporation (CCBC), a leading provider of cord blood collection, laboratory testing, hematop...
Singapore: RNL Bio filed an Investigational New Drug (IND) application with the Korean Food and Drug Administration (KFD...
Singapore: RNL Bio has signed the agreement with RST Biomedikal Sanayi, a Turkish company, to license RNL Bio's stem ce...
Singapore: An investigator-sponsored clinical study in Japan using Cytori's Celution System for treatment of cryptoglan...
Singapore: In the first study of its kind, researchers at one of Korea's leading university and the RNL Bio Stem Cell Te...
Singapore: Scientists at A*STAR's Genome Institute of Singapore (GIS) and the Max Planck Institute for Molecular Genetic...
Singapore: Scientists of the RNL Stem Cell Technology Institute, Korea, transplanted own stem cells of patients suffer...
Singapore: Cell culture is going to become the next big pharmaceutical trend, as laboratories rush to meet demand for st...
Started with an initial investment of Rs4.5 crore two years ago, Regenerative Medical Services (RMS Regrow Regrow) is a ...
In South Korea, two research teams led by Prof. Park Se-pill at Jeju National University Stem Cell Research Center and M...
Singapore: A clinical trial at the University of Cincinnati is looking at how a patient's own stem cells may treat angin...
Singapore: A team of scientists led by Stowers investigator, Dr Ali Shilatifard, has revealed that stem cells are always...
Singapore: Researchers at North Carolina (NC) State University, US, have revealed that a protein known as Sp2 is key to ...
Singapore: Kyoto University has been granted four patents relating to its basic iPS cell technology, one in Japan and th...
Singapore: Scientists have discovered that the heart's own stem cells can be used to repair damaged parts of the heart. ...
The Nobel prize for Physiology to two stem cell research scientists in 2012 has firmly put the spotlight on this promisi...
Singapore: ClinACE has collaborated with a stem cell banking and therapy company for conducting end-to-end clinical deve...
Singapore: Dr Shinya Yamanaka, director of the Center for iPS Cell Research and Application (CiRA), Kyoto University, ha...
Bangalore: LifeCell International, India's largest and most accredited stem cell bank, secured an investment of $7 milli...
The pioneering research of Nobel Laureates Sir John Gurdon and Dr Shinya Yamanaka on reprogramming adult stem cells has ...
Singapore: US-based Osiris Therapeutics, which develops and markets stem cell products to treat serious medical conditio...
Singapore: Dr Jeong-Chan Ra, founder and director of RNL Bio, a biotechnology R&D firm based in Seoul, South Korea, ...
Singapore: Cell Therapy Limited (CTL), which is based in Cardiff, UK, entered into a joint venture (JV) agreement with C...
Embryonic stem (ES) cells possess unique therapeutic potential due to their ability to give rise to all the cells of the...
Singapore: Tisch MS Research Center of New York has received Investigational New Drug (IND) approval from the Food and D...
Singapore: A study conducted by Beike Biotechnology Company in conjunction with physicians and researchers at two Chines...
Singapore: Senior scientists from Australia and China are meeting at the Australian Academy of Science on July 23 and 24...
Singapore: Europe based Bone Therapeutics, a regenerative therapy company, has received clearance from the Competent Aut...
Singapore: A*STAR invited the 2012 Nobel Laureate in Medicine or Physiology, Professor Shinya Yamanaka, to give a lectur...
"When I saw the embryo, I suddenly realized there was such a small difference between it and my daughters. I thought, we...
Singapore: Life science experts in China have called for more effective regulation in the domain of stem cell treatments...
LifeCell International, India's largest private stem cell bank and the first stem cell solution provider to bring the co...
Singapore: US-based Human Biostar and South Korea-based RNL Bio have completed the revision and supplementation of the f...
Bangalore: LifeCell, one of India's largest stem cell banking companies recently revealed that in addition to facilitati...
Singapore: Australian company Mesoblast has outlined the company's strategic plans to develop adult stem cell therapies...
Bangalore: GE Healthcare, and BGI, the world's largest genomics organization, have entered into a pioneering multi-year ...
Singapore: US-based BioTime submitted a Clinical Investigation Protocol (CIP) to European regulatory authorities for app...
Singapore: Scientists at the University of Sheffield have discovered a new compound that could prevent ageing by delayin...
Singapore: Stemtech International, a pioneer in stem cell nutrition, has signed an exclusive business deal with Marinova...
Singapore: Life Technologies has extended its collaborative agreement with Japanese firm DNAVec Corporation to launch Cy...
Singapore: Dr Rongxiang Xu, the founder of 'human body regenerative restoration science' and a renowned medical scienti...
Australia-based Mesoblast is one-of-the-world's leading developer of innovative biological products in regenerative medi...
Singapore: US-based Medistem has entered into a collaboration with Superview Biotechnology, a subsidiary of Yinhuan Hold...
Singapore: In a first, Health Canada has approved marketing of Prochymal (remestemcel-L), a stem cell therapy by Osiris ...
Singapore: A research conducted by Fabrice Chretien of France's Pasteur Institute, has revealed that some stem cells can...
Singapore: A team of researchers from Scotland's Heriot-Watt University have developed a 3D printer that can print human...
Singapore: Dr Loh Yuin Han Jonathan, Principal Investigator at A*STAR's Institute of Molecular and Cell Biology (IMCB) h...
Singapore: Taiwan based ScinoPharm, engaged in development and manufacture of active pharmaceutical ingredients has clos...
‎Singapore: Miltenyi Biotec, a cell innovation company, has opened a new office in Seoul, South Korea, enlarging t...
Singapore: Sutter Institute for Medical Research and Cord Blood Registry (CBR), which is the world's largest stem cell b...
Singapore: A study published in Cell Stem Cell revealed that diabetes drug metformin encourages the growth of new neuron...
Singapore: Scientists funded by the Medical Research Council (MRC) have carried out the first successful transplant of l...
Singapore: ReproCELL, a Japanese stem cell technology company, has opened the company's first branch and US office in Bo...
Singapore: Scientists at The Scripps Research Institute (TSRI), US, have found a way to transform bone marrow stem cells...
Singapore: A new study by Reports and Reports predicted that the stem cell therapy market in Asia Pacific (APAC) will gr...
Singapore: Australia's Allied Healthcare's CardioCel tissue patches has shown superiority for stem cells survival and gr...
Development of stem cell therapies requires innovative technologies and processes to overcome safety concerns and VeriSt...
Sinapore: LifeMap Sciences, subsidiary of BioTime, has launched LifeMap Discovery, a roadmap of embryonic development an...
Blockbusters and super profits. Will the bioscience industry in this decade see these words come to life? More important...
Singapore: Adelaide-based biotechnology company Bionomics has strengthened its presence in the US with the acquisition o...
Singapore: A study conducted by Dr Steven Goldman and his team at the University of Rochester Medical Center (URMC), US,...
Singapore: Biokine Therapeutics received orphan drug designation from the US FDA for the mobilization of hematopoietic s...
Singapore: Swedish doctors have for the first time in history been able to pair the groin vein of a dead donor with stem...
Singapore: Osiris Therapeutics, a Columbia-based company focused on developing and marketing stem cell products to treat...
Singapore: Australian regenerative medicine firm, Orthocell, is looking ahead to raise $8 million through an Initial Pub...
Singapore: Cytori Therapeutics announced that a 40-patient, multi-center investigator-sponsored and funded clinical stu...
Singapore: Australian regenerative drug company, Mesoblast, is planning to expand its global manufacturing base and the ...
Singapore: Korean scientists have developed a breakthrough technology that can more efficiently and safely reprogram adu...
Singapore: A research team at the tissue regeneration materials unit, National Institute for Materials Science (NIMS), s...
Singapore: Australia's Genea Stem Cells, a supplier and developer of disease-specific human stem cells, has been success...
Singapore: Researchers from the University of Zurich have discovered a gene that plays a central role in black skin canc...
Singapore: Osiris Therapeutics has received consent from New Zealand to market its first-in-class stem cell therapy Proc...
Singapore: The Stem Cell Society Singapore (SCSS) is holding its 4th Annual Symposium on September 6-7, 2012, at the Bio...
Singapore: A study conducted by Beike Biotechnology Company in conjunction with physicians and researchers at two Chines...
Singapore: Sooam Biotech Research Foundation of Korea has signed an agreement with Russia's North-Eastern Federal Univer...
"It has been Dr Silviu Itescu's extraordinary vision and intellectual rigor that has underpinned Mesoblast's resounding ...
Singapore, May 22, 2012: Canadian company, Osiris Therapeutics has received market authorization from Health Canada to m...
US based Pelical BioThermal which is a global leader providing the broadcast and most innovative range of temperature-co...
